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POST·TAMPONADE
Quantitation of Apical Right Ventricular Collapse
In Tamponade: A Diagnostic Improvement
DURING TAMPONADE
together 142 lesions from 34 HL and 16 NL were analyzed quantitatively
using cinedensitometry. Lesions which PTCA wire crossed were separately
assessed. Average serum LDL-C levels improved from 166 to 117 mg/dl on
drug and diet (p < 0.001) in HL. Seven out of 92 non-IRL (7.6%) exhibited pro-
gression defined as ::;0.5 mm decrease of minimum lesion diameter, and 9
IRL (9.8%) did regression ::;0.5 mm increase. Whereas thirty five IRL showed
significantly more incidence of regression (9 sites, 25.7% p = 0.021) and sim-
ilar rate of progression (3 pts, 8.6%). An improvement of LDL-C/HDL-C ratio
was more prominent in patients with IRL regression compared with those
showing progression or no change (p < 0.05).
Thus the IRL was found in favor of more regression than non-IRL, and the
magnitude of lesion regression can be expected according to the effect of
lipid lowering treatment in patients after AMI.
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Right ventricular (RV) collapse, a popular echocardiographic sign of tampon-
ade is a subjective call with no precise criteria. RV collapse is usually diag-
nosed by early diastolic "dimpling" or local concavity of RV anterior wall in
parasternal views. In 15 patients with pericardial effusion studied (A) during
tamponade, and (B) after relief of tamponade, we noted that definite such
"dimpling" could be seen in only five out of ten cases, while in six patients
parasternal window was inadequate. In contrast, the apical four-chamber
view could be obtained in all 15 patients. In this view we made several RV
measurements including various transverse RV dimensions, RV area and ra-
tios of these to the corresponding LV measurements.
Results: LV width/RV width ratio at the junction of the apical 1/4 to basal
3/4 of LV length showed the best separation between tamponade and post-
tamponade values (p < 0.005). Using a cut-off value of LV width/RV width
::;3 as indicative of tamponade. This criterion showed no overlap between
tamponade and post-tamponade values.
Conclusion: Ratio of LV width to RV width ::;3, measured at the junction of
apical 1/4 with basal 3/4 of LV, is a promising sign of tamponade, reflecting
selectively greater collapse of near-apical region of RV in tamponade.
Pericardial constraint may be an important feature in chronic heart failure
(CHF). We hypothesized that baseline pericardial constraint could be inferred
if left ventricular end-diastolic volume (LVEDV) paradoxically increased dur-
ing lower body negative pressure (LBNP). as a consequence of abolition of
constraint with an increase in the left ventricular transmural and transseptal
pressure gradients.
Methods: 11 patients with CHF and left ventricular ejection fraction <35%
(age 34-82, mean 51.5 years; 8 male, 3 female) were compared with 6
healthy controls (age 31-61, mean 50.5 years; all male). Radionuclide ven-
Demonstration of Pericardial Constraint in
Chronic Heart Failure
John J. Atherton, Suhas S. Lele, Helen L. Thomson, Karen N. Wright, Gerry
w.F. Muehle, Thomas Moore, Israel Belenkie, Andrew J. Galbraith, John V Tyberg,
Michael P Frenneaux. Departments of Medicine, University of Queensland, Australia;
University of Calgary, Canada
Ivan A. D'Cruz, Alzal ur Rehman. Medical Col/ege of Georgia and Veterans
Administration Medical Center, Augusta. Georgia
\1007-171
11007-161
48± 10(mOD)
79 ± 27
**562± 155
**440 ± 269
Hirulog'· vs. Heparin During Percutaneous
Transluminal Coronary Angioplasty in Patients
with Post-Infarction Angina: Results of the
Myocardial Infarction Arm of the Hirulog
Angioplasty Trial
Regression of Infarct-Related Coronary Lesions
on Aggressive Lipid Lowering Treatment in
Patients After Recovery from Acute Myocardial
Infarction
A Prognostic Factor in Coronary Artery Disease
(CAD): Platelet-Dependent Thrombin Generation
in Patients with CAD
Nobuo Aoki, Isao Aoki, Hideaki Yoshino, Akira Maki, Katsuya Shimoyama,
Masashi Homori, Atsuo Yanagisawa, Kyozo Ishikawa. Kyorin University, Tokyo, Japan
Control(n = 12)
Stable angina (SAP) (n ~ 15)
Unstable angina IUAPI In ~ 15)
Acute myocardial infarct (AMI) In ~ 43)
**p < 0.01 compared to SAP
[ 1006-441
John Strony, John A. Bittl, Ezra Deutsch, Russell Ivanhoe, Clyde Meckel,
Burt Adelman, Hirulog Angioplasty Study Investigators. Case Western Reserve
University, Cleveland, OH
Acute intervention for recurrent angina following an acute myocardial infarc-
tion continues to present as a therapeutic challenge to the physician. Stan-
dard anticoagulation using heparin during PTCA in patients with post infarc-
tion angina is associated with a 16% incidence of abrupt vessel closure and
an 11 % incidence of death, CABG, and recurrent MI. The ability of Hirulog'"
(BG8967). a direct thrombin inhibitor, to improve PTCA outcome was com-
pared in a double blind fashion to heparin in the PhasE: III Hirulog Angioplasty
Trial. Clinical and angiographic results from the post infarction subgroup (n
= 635) will be reported. Patients were randomized to either Hirulog '" (2.2
mglkg bolus and 1.0 mglkg/hr infusion) or heparin (175 Ulkg bolus and 15
Ulkglhr infusion). Additional boluses were administered in order to maintain
a minimum activated clotting time of 350 seconds. The primary endpoint was
procedural failure (impending or established abrupt vessel closure, bypass
surgery, recurrent MI, or death) with a secondary endpoint of major hemor-
rhage. The event rates in this 635 patient subgroup were: Death 0.8% (n =
5). Emergency Bypass 2.2% (n = 14), Recurrent Myocardial Infarction 2.5%
(n = 16). Abrupt vessel closure 5.8% (n = 37). and Major Hemorrhage 6.8%
(n = 431.
In summary, this study will determine: (1) whether Hirulog'", a direct
thrombin inhibitor, is superior to heparin when used during PTCA in patients
with post-infarct angina and (2) the overall safety profile of Hirulog'" in this
subgroup.
We examined platelet-dependent thrombin generation in patients with coro-
nary artery disease ICAD). Thrombin generation was measured according to
the method of Aronson et al (Circulation, 1992). 0.5 ml of platelet rich plasma
(PRP, 15 x 104/ml) was prepared, and 40 mM of Cael, was added to start clot-
ting. 0.5 mM of S-2238 was added to each sample in a microtiter plate every
10 min, and the plate was read kinetically at a wavelength of 405 nm on a
microtiter plate reader. The patients with CAD devided into 3 groups.
Thrombin generation 20 min after CaCI2, additon is:
The patients with UAP and AMI showed marked increase in thrombin gen-
eration compared to SAP and control subjects. AMI patients with severe
coronary artery disease (Group B) showed higher levels of thrombin gen-
eration (Group A, Gensini score < 32: 382 ± 248 mOD vs Group B, Gensini
score> 31: 578 ± 238, P < 0.05). LVEF of group A is significantly higher than
that of group B (P < 0.05). These findings indicate that patients with UAP and
AMI have an evidence of hypercoagulable states and that platelet-dependent
thrombin generation may play an important role in pathophysiology of UAP
or AMI, and may be a prognostic factor in CAD.
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Considering of remained active nature of infarct-related lesion IIRL) early af-
ter recovery from acute myocardial infarction (AMI). a prospective study was
undertaken to determine whether IRL exhibits more regression on aggres-
sive lipid lowering treatment. Fifty patients (pts), 34 hyperlipemic (HL) and 16
normal lipids (NL), aged::::: 65 year with coronary diameter stenosis >25%
were followed monthly. LDL-cholesterol (LDL-C) level was aimed to control
below 130 mg/dl in HL patients on strict diet and pravastatin 10-30 mg/day,
also LDL-apheresis in a patient with familier hyperlipemia. Repeat coronary
angiography was performed in average 14 months after AMI onset. and al-
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